Rare case of microglandular-like adenocarcinoma of endometrium

Abstract

This paper focuses on the microglandular-like pattern, a rare pattern of endometrial carcinoma whose appearance resembles microglandular hyperplasia of the endocervix. Its similarity with benign lesions makes diagnosis of this pattern of carcinoma difficult, particularly in minute specimens. Moreover, it raises a question of whether the tumor originates from the uterine corpus or the cervix. Microglandular-like adenocarcinoma of the endometrium may be an individual type of carcinoma or combined with endometrioid or mucinous carcinoma. The immunohistochemical evaluation is recommended for precise diagnosis: microglandular-like adenocarcinoma expresses markers typical for cervical carcinomas (p16, СК17, and carcinoembryonic antigen) and endometrial carcinomas (estrogen, vimentin, and CD10). The presence of foamy macrophages in the stroma of the tumor and intraglandular foci of squamous differentiation help in the differential diagnosis of microglandular hyperplasia of the endocervix. Immunohistochemical evaluation also facilitates differential diagnosis: a negative PAX2 expression and a high mitotic index (Ki-67 >10%) indicate a microglandular-like adenocarcinoma.

Keywords

endometrial neoplasms / endometrioid carcinoma / immunohistochemistry / oncology / case report

References

[1] Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi: 10.3322/caac.21660

[2] Sung H., Ferlay J., Siegel R.L., et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries // CA Cancer J Clin. 2021. Vol. 71, N 3. P. 209–249. doi: 10.3322/caac.21660

[3] Makker V, MacKay H, Ray-Coquard I, et al. Endometrial cancer. Nat Rev Dis Primers. 2021;7(1):88. doi: 10.1038/s41572-021-00324-8

[4] Makker V., MacKay H., Ray-Coquard I., et al. Endometrial cancer // Nat Rev Dis Primers. 2021. Vol. 7, N 1. P. 88. doi: 10.1038/s41572-021-00324-8

[5] Henley SJ, Ward EM, Scott S, et al. Annual report to the nation on the status of cancer, part I: national cancer statistics. Cancer. 2020;126(10):2225–2249. doi: 10.1002/cncr.32802

[6] Henley S.J., Ward E.M., Scott S., et al. Annual report to the nation on the status of cancer, part I: national cancer statistics // Cancer. 2020. Vol. 126, N 10. P. 2225–2249. doi: 10.1002/cncr.32802

[7] WHO Classification of Tumours Editorial Board. WHO Classification of Tumours of Female Reproductive Organs. 5th ed. Lyon: International Agency for Research on Cancer; 2020.

[8] WHO Classification of Tumours Editorial Board. WHO Classification of Tumours of Female Reproductive Organs. 5th ed. Lyon : International Agency for Research on Cancer, 2020.

[9] Rutgers JK. Update on pathology, staging and molecular pathology of endometrial (uterine corpus) adenocarcinoma. Future Oncol. 2015;11(23):3207–3218. doi: 10.2217/fon.15.262

[10] Rutgers J.K. Update on pathology, staging and molecular pathology of endometrial (uterine corpus) adenocarcinoma // Future Oncol. 2015. Vol. 11, N 23. P. 3207–3218. doi: 10.2217/fon.15.262

[11] Young RH, Scully RE. Uterine carcinomas simulating microglandular hyperplasia. A report of six cases. Am J Surg Pathol. 1992;16(11):1092–1097. doi: 10.1097/00000478-199211000-00008

[12] Young R.H., Scully R.E. Uterine carcinomas simulating microglandular hyperplasia. A report of six cases // Am J Surg Pathol. 1992. Vol. 16, N 11. P. 1092–1097. doi: 10.1097/00000478-199211000-00008

[13] Rabban J. Problematic endometrial biopsies: potential under-diagnosis of malignancy. Current issues in anatomic pathology. University of California San Francisco, 2017. Available from: https://www.ucsfcme.com/2017/MAP17001A/slides/05_Rabban_Endometrial.pdf

[14] Rabban J. Problematic endometrial biopsies: potential under-diagnosis of malignancy. Current issues in anatomic pathology. University of California San Francisco, 2017. Режим доступа: https://www.ucsfcme.com/2017/MAP17001A/slides/05_Rabban_Endometrial.pdf

[15] Malpica A. How to approach the many faces of endometrioid carcinoma. Mod Pathol. 2016;29 suppl. 1:S29–S44. doi: 10.1038/modpathol.2015.142

[16] Malpica A. How to approach the many faces of endometrioid carcinoma // Mod Pathol. 2016. Vol. 29 (suppl. 1). P. S29–S44. doi: 10.1038/modpathol.2015.142

[17] Clement PB, Young RH. Endometrioid carcinoma of the uterine corpus: a review of its pathology with emphasis on recent advances and problematic aspects. Adv Anat Pathol. 2002;9(3):145–184. doi: 10.1097/00125480-200205000-00001

[18] Clement P.B., Young R.H. Endometrioid carcinoma of the uterine corpus: a review of its pathology with emphasis on recent advances and problematic aspects // Adv Anat Pathol. 2002. Vol. 9, N 3. P. 145–184. doi: 10.1097/00125480-200205000-00001

[19] Azueta A, Gatius S, Matias-Guiu X. Endometrioid carcinoma of the endometrium: pathologic and molecular features. Semin Diagn Pathol. 2010;27(4):226–240. doi: 10.1053/j.semdp.2010.09.001

[20] Azueta A., Gatius S., Matias-Guiu X. Endometrioid carcinoma of the endometrium: pathologic and molecular features // Semin Diagn Pathol. 2010. Vol. 27, N 4. P. 226–240. doi: 10.1053/j.semdp.2010.09.001

[21] Young RH, Clement PB. Malignant lesions of the female genital tract and peritoneum that may be underdiagnosed. Semin Diagn Pathol. 1995;12(1):14–29.

[22] Young R.H., Clement P.B. Malignant lesions of the female genital tract and peritoneum that may be underdiagnosed // Semin Diagn Pathol. 1995. Vol. 12, N 1. P. 14–29.

[23] Qiu W, Mittal K. Comparison of morphologic and immunohistochemical features of cervical microglandular hyperplasia with low-grade mucinous adenocarcinoma of the endometrium. Int J Gynecol Pathol. 2003;22(3):261–265. doi: 10.1097/01.PGP.0000071043.12278.8D

[24] Qiu W., Mittal K. Comparison of morphologic and immunohistochemical features of cervical microglandular hyperplasia with low-grade mucinous adenocarcinoma of the endometrium // Int J Gynecol Pathol. 2003. Vol. 22, N 3. P. 261–265. doi: 10.1097/01.PGP.0000071043.12278.8D

[25] Chekmaeva M, Elleson LH, Pirog EC. Immunohistochemical differences between mucinous and microglandular adenocarcinomas of the endometrium and benign endocervical epithelium. Int J Gynecol Pathol. 2008;27(4):547–554. doi: 10.1097/PGP.0b013e318177eadc

[26] Chekmaeva M., Elleson L.H., Pirog E.C. Immunohistochemical differences between mucinous and microglandular adenocarcinomas of the endometrium and benign endocervical epithelium // Int J Gynecol Pathol. 2008. Vol. 27, N 4. P. 547–554. doi: 10.1097/PGP.0b013e318177eadc

[27] Jacques SM, Qureshi F, Lawrence WD. Surface epithelial changes in endometrial adenocarcinoma: diagnostic pitfalls in curettage specimens. Int J Gynecol Pathol. 1995;14(3):191–197. doi: 10.1097/00004347-199507000-00001

[28] Jacques S.M., Qureshi F., Lawrence W.D. Surface epithelial changes in endometrial adenocarcinoma: diagnostic pitfalls in curettage specimens // Int J Gynecol Pathol. 1995. Vol. 14, N 3. P. 191–197. doi: 10.1097/00004347-199507000-00001

[29] Da Forno PD, McGregor AH, Brown LJR. Microglandular hyperplasia: a pitfall in the diagnosis of microglandular type endometrioid adenocarcinoma. Histopathology. 2005;46(3):346–358. doi: 10.1111/j.1365-2559.2004.01988.x

[30] Da Forno P.D., McGregor A.H., Brown L.J. Microglandular hyperplasia: a pitfall in the diagnosis of microglandular type endometrioid adenocarcinoma // Histopathology. 2005. Vol. 46, N 3. P. 346–358. doi: 10.1111/j.1365-2559.2004.01988.x

[31] Stewart CJR, Crook ML. PAX2 and cyclin D1 expression in the distinction between cervical microglandular hyperplasia and endometrial microglandular-like carcinoma: a comparison with p16, vimentin, and Ki-67. Int J Gynecol Pathol. 2014;34(1):90–100. doi: 10.1097/PGP.0000000000000107

[32] Stewart C.J.R., Crook M.L. PAX2 and cyclin D1 expression in the distinction between cervical microglandular hyperplasia and endometrial microglandular-like carcinoma: a comparison with p16, vimentin, and Ki-67 // Int J Gynecol Pathol. 2014. Vol. 34, N 1. P. 90–100. doi: 10.1097/PGP.0000000000000107

[33] Malpica A, Euscher ED. Biopsy interpretation series. Biopsy interpretation of the uterine cervix and corpus. 2nd ed. Wolters Kluwers; 2015.

[34] Malpica A., Euscher E.D. Biopsy interpretation series. Biopsy interpretation of the uterine cervix and corpus. 2nd ed. Wolters Kluwers, 2015.

[35] Pavlakis K, Vrekoussis T, Messini I, et al. Mucinous epithelial lesions in endometrial curettage material: a diagnostic challenge. Appl Immunohistochem Mol Morphol. 2012;20(6):607–613. doi: 10.1097/PAI.0b013e31825251a4

[36] Pavlakis K., Vrekoussis T., Messini I., et al. Mucinous epithelial lesions in endometrial curettage material: a diagnostic challenge // Appl Immunohistochem Mol Morphol. 2012. Vol. 20, N 6. P. 607–613. doi: 10.1097/PAI.0b013e31825251a4

RIGHTS & PERMISSIONS

Eco-Vector